These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7037511)

  • 1. The effect of insulin antibodies on insulin dose and diabetic control.
    Walford S; Allison SP; Reeves WG
    Diabetologia; 1982 Feb; 22(2):106-10. PubMed ID: 7037511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change of insulin dosage, circulating free and bound insulin and insulin antibodies on transferring diabetics from conventional to highly purified porcine insulin.
    Asplin CM; Hartog M; Goldie DJ
    Diabetologia; 1978 Feb; 14(2):99-105. PubMed ID: 631462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating insulin antibodies during therapy with highly purified neutrally buffered insulins including desphe insulins. Report of a prospective study with 40 cases.
    Kühnau J; Rüdiger H; Goetz K
    Exp Clin Endocrinol; 1984 Apr; 83(2):161-7. PubMed ID: 6373318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic control in patients treated with once or twice-daily insulin injections, including a comparison of conventional beef and highly purified pork insulins.
    Gray RS; Borsey DQ; Fraser DM; Kurtz AB; Rainbow S; Smith AF; Duncan LJ; Clarke BF
    Diabetologia; 1981 Sep; 21(3):206-10. PubMed ID: 7028552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of new insulins on insulin and C-peptide antibodies, insulin dose, and diabetic control.
    Peacock I; Tattersall RB; Taylor A; Douglas CA; Reeves WG
    Lancet; 1983 Jan; 1(8317):149-52. PubMed ID: 6130198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin antibodies: reduction in various anti-insulin IgG subclasses with human insulin therapy.
    Kumar D
    Horm Metab Res; 1993 Jul; 25(7):360-4. PubMed ID: 8406321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of "fractionated" insulins on total plasma insulin binding capacity and insulin requirements in severe diabetes.
    Oakley NW
    Lancet; 1976 May; 1(7967):994-6. PubMed ID: 57444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical comparison of purified bovine and purified porcine insulins.
    Olczak SA; Greenwood RH
    Postgrad Med J; 1985 Jan; 61(711):15-8. PubMed ID: 3887349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfer from purified porcine insulins to semisynthetic human insulins decreases insulin antibodies and circulating immune complexes in diabetic children and adolescents. A two-year follow-up.
    Dorchy H; Duchateau J; Bosson D; D'Hooge D
    Diabete Metab; 1989; 15(3):107-10. PubMed ID: 2668052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of highly purified bovine insulin: a comparison with conventional bovine and highly purified human insulins.
    Wilson RM; Douglas CA; Tattersall RB; Reeves WG
    Diabetologia; 1985 Sep; 28(9):667-70. PubMed ID: 3905477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective IgG subclass antibody response to insulin in diabetic patients receiving animal insulin replacement therapy.
    Siddiqi MA; Wangnoo SK
    Int Arch Allergy Appl Immunol; 1989; 89(1):49-53. PubMed ID: 2659538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of purified bovine and monocomponent porcine insulins.
    Johnson Z; McDonnell J; Devlin JG
    Ir Med J; 1984 Dec; 77(12):380-1, 383. PubMed ID: 6394540
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin allergy: differences in the binding of porcine, bovine, and human insulins with anti-insulin IgE.
    Kumar D
    Diabetes Care; 1981; 4(1):104-7. PubMed ID: 7009106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin binding capacity in patients changed from conventional to highly purified insulins. An indicator of likely response.
    Mustaffa BE; Daggett PR; Nabarro JD
    Diabetologia; 1977 Aug; 13(4):311-5. PubMed ID: 562300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of bovine, porcine and semisynthetic human insulin.
    Venekamp WJ; van der Hooft JC; Jacobsen L; van Schaik CL
    Neth J Med; 1985; 28 Suppl 1():57-8. PubMed ID: 3892343
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of IgE antibodies to human (recombinant DNA), porcine, and bovine insulins in diabetic subjects.
    Fireman P; Fineberg SE; Galloway JA
    Diabetes Care; 1982; 5 Suppl 2():119-25. PubMed ID: 6765521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential response to infusions of highly purified and conventional bovine and porcine insulins.
    Nosadini R; Noy G; Kurtz AB; Alberti KG
    Diabetes; 1981 Aug; 30(8):650-5. PubMed ID: 7018969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The production and characteristics of anti-insulin, anti-A-component and anti-proinsulin antibodies in patients treated with monocomponent or conventional insulin.
    Kawazu S; Kanazawa Y; Miki E; Hayashi M; Sando H; Kajinuma H; Iwamoto Y; Akanuma Y; Kosaka K
    Acta Diabetol Lat; 1979; 16(4):339-51. PubMed ID: 399151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating IgG antibody to protamine in patients treated with protamine-insulins.
    Kurtz AB; Gray RS; Markanday S; Nabarro JD
    Diabetologia; 1983 Oct; 25(4):322-4. PubMed ID: 6196244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin antibody response to bovine insulin therapy: functional significance among insulin requiring young diabetics in India.
    Goswami R; Jaleel A; Kochupillai NP
    Diabetes Res Clin Pract; 2000 Jul; 49(1):7-15. PubMed ID: 10808058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.